期刊文献+

玻璃体切除硅油填充术后高眼压19例 被引量:22

The clinical observation of hypertony after pars plana vitrectomies and silicone oil injection
在线阅读 下载PDF
导出
摘要 目的:探讨玻璃体切除硅油填充术后眼压的变化规律及可能与术后高眼压发生相关的因素。方法:前瞻性非对照临床病例观察。35例35眼行玻璃体切除硅油填充手术的患者。观察由同一术者经睫状体平坦部行玻璃体切除硅油填充手术患者,记录病史、检查、手术情况,Goldmann眼压计测量术前2,6,24h;术后2,6,24h;2,3d;1,2wk;1,2,3mo的眼压。结果:术前术眼平均眼压为12.59±6.11mmHg(1mmHg=0.133kPa),术后眼压比术前眼压高(P=0.000)。术后6h眼压最高,为27.43±10.54mmHg。术后19眼(54%)眼压>25mmHg,本文将眼压>25mmHg定义为高眼压。7眼(20%)眼压>35mmHg;最高眼压52mmHg。19眼高眼压眼中16眼的高眼压发生在术后6h内,5眼(14%)的高眼压持续超过3mo。未发现高眼压与术前眼压、糖尿病、环扎之间的相关关系。结论:玻璃体切除硅油填充术后高眼压发生比例较高,而且眼压升高多发生在手术后6h内,眼压的升高幅度大,需要及时处理;部分患者术后高眼压的持续时间长,需长期观察。 AIM: To investigate the regulations of changes in intraocular pressure (IOP) and the possible factors of postoperative ocular hypertony after PPV and SOI. METHODS: The study was performed in patients who had been operated with PPV and SOI by the one ophthalmologist. The medical histories and the examination were done by the same ophthalmologist. IOPs were measured with Goldmann tonometer at 2, 6, 24h before surgery, and 2,6,24h; 2, 3d; 1, 2wk; 1, 2, 3mo postoperatively. RESULTS: The mean preoperatively IOP was 12.59± 6.11mmHg. The postoperatively IOP was higher than the preoperatively IOP, and the highest was at 6h which was 27.43± 10.54mmHg. There were 19 eyes (54%) whose postoperatively IOP 〉25mmHg and 7 eyes (20%) 〉 35mmHg. The highest postoperatively IOP was 52mmHg. There were no significant correlation between hypertony and IOP, diabetic and scleral bucking. CONCLUSION: The most of postoperaUvely hypertony occurs in 6h after surgery, and will last a long time. It needs to be treated early and observed for a long period.
出处 《国际眼科杂志》 CAS 2006年第2期400-403,共4页 International Eye Science
关键词 玻璃体切除术 硅油填充术 高眼压 手术后并发症 PPV SOI hypertony postoperativecomplication
  • 相关文献

参考文献8

二级参考文献28

  • 1吴燮灿.实用眼镜光学[M].杭州:浙江省视学-光觉出版社,1996.4-192.
  • 2Krause L, Kreusel KM, Jandeck C, Kellner U, Foerster MH. Vitrectomy in advanced Coats disease [J]. Ophthalmologe,2001;98(4):387-390.
  • 3Miller DM, Benz MS, Murray TG, Dubovy SR. Intraretinal calcification and osseous metaplasia in coats disease [J]. Arch Ophthalmol,2004;122(11):1710-1712.
  • 4Shields JA, Shields CL, Honavar SG, Demirci H. Clinical variations and complications of Coats disease in 150 cases: the 2000 Sanford Gifford Memorial Lecture [J]. Am J Ophthalmol,2001;131(5):561-571.
  • 5Cerbulescu BJ, Stefan C. Coats disease [J]. Oftalmologia,,2003;58(3):21-25.
  • 6Nucci P, Bandello F, Serafmo M, Wilson ME. Selective photocoagulation in Coats disease: ten-year follow-up [J]. Eur J Ophthalmol,2002;12(6):501-505.
  • 7Berzas C, Richard G. Therapy of retinal detachment in Coats disease [J].Nippon Ganka Gakkai Zasshi,1996;88:598-602.
  • 8Egerer I, Tasman W, Tomer TL. Coats disease [J]. Arch Ophthalmol,1974;92:109-112.
  • 9Kiratli H, Eldem B. Management of moderate to advanced Coats disease [J].Ophthalmologica, 1998; 212(1):19-22.
  • 10Yoshizumi MO, Kreiger AE, Lewis H, Foxman B, Hakakha BA.Vitrectomy techniques in late-stage Coats-like exudative retinal detachment [J]. Doc Ophthalmol, 1995;90:387-394.

共引文献32

同被引文献460

引证文献22

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部